Literature DB >> 1721259

Practical aspects of FK 506 analysis (Pittsburgh experience).

V S Warty1, R Venkataramanan, P Zendehrouh, S Mehta, T McKaveney, J Flowers, S Zuckerman, A Krajak, A Zeevi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721259      PMCID： PMC2972718     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

Review 1.  Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics.

Authors:  T E Starzl; K Abu-Elmagd; A Tzakis; J J Fung; K A Porter; S Todo
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

2.  The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.

Authors:  K Abu-Elmagd; J J Fung; M Alessiani; A Jain; R Venkataramanan; V S Warty; S Takaya; S Todo; W D Shannon; T E Starzl
Journal:  Transplantation       Date:  1991-07       Impact factor: 4.939

3.  A highly sensitive method to assay FK-506 levels in plasma.

Authors:  K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066
  3 in total
  12 in total

1.  Low-dose of FK 506 and associated blood levels in allotransplantation of rat liver, heart, and skin.

Authors:  X Cai; J Harnaha; P N Rao; J Flowers; R Venkataramanan; V Warty; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1992-08       Impact factor: 1.066

Review 2.  In vitro assessment of FK 506 immunosuppressive activity in transplant patients.

Authors:  A Zeevi; R Venkataramanan; V Warty; G Eiras; M Woan; K Abu-Elmagd; M Alessiani; A Jain; A J Demetris; T Zerbe
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

3.  FK506 measurement: comparison of different analytical methods.

Authors:  V Warty; S Zuckerman; R Venkataramanan; J Lever; J Fung; T Starzl
Journal:  Ther Drug Monit       Date:  1993-06       Impact factor: 3.681

4.  Fluconazole therapy in transplant recipients receiving FK506.

Authors:  R Mañez; M Martin; D Raman; D Silverman; A Jain; V Warty; I Gonzalez-Pinto; S Kusne; T E Starzl
Journal:  Transplantation       Date:  1994-05-27       Impact factor: 4.939

5.  FK 506 in small bowel transplant recipients: pharmacokinetics and dosing.

Authors:  A Jain; R Venkataramanan; J Lever; V Warty; K Abu-Elmagd; H Furukawa; J Reyes; B Nour; A Asrian; A Tzakis
Journal:  Transplant Proc       Date:  1994-06       Impact factor: 1.066

6.  Pregnancy after liver transplantation under tacrolimus.

Authors:  A Jain; R Venkataramanan; J J Fung; J C Gartner; J Lever; V Balan; V Warty; T E Starzl
Journal:  Transplantation       Date:  1997-08-27       Impact factor: 4.939

7.  Tacrolimus analysis: a comparison of different methods and matrices.

Authors:  V Warty; S Zuckerman; R Venkataramanan; J Lever; J Chao; T Mckaveney; J Fung; T Starzl
Journal:  Ther Drug Monit       Date:  1995-04       Impact factor: 3.681

Review 8.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 9.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 10.  Clinical pharmacokinetics of tacrolimus.

Authors:  R Venkataramanan; A Swaminathan; T Prasad; A Jain; S Zuckerman; V Warty; J McMichael; J Lever; G Burckart; T Starzl
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.